Distinguishing among incretin-based therapies. Pathophysiology of type 2 diabetes mellitus: potential role of incretin-based therapies.

Campbell, R Keith

Distinguishing among incretin-based therapies. Pathophysiology of type 2 diabetes mellitus: potential role of incretin-based therapies. [electronic resource] - The Journal of family practice Sep 2010 - S5-9 p. digital

Publication Type: Case Reports; Journal Article

1533-7294


Adamantane--analogs & derivatives
Aged
Blood Glucose
Diabetes Mellitus, Type 2--drug therapy
Dipeptides--therapeutic use
Exenatide
Female
Glucagon--metabolism
Glucagon-Like Peptide 1--analogs & derivatives
Humans
Hypoglycemic Agents--therapeutic use
Incretins--therapeutic use
Insulin-Secreting Cells--physiology
Liraglutide
Male
Metformin--therapeutic use
Middle Aged
Peptides--therapeutic use
Pyrazines--therapeutic use
Severity of Illness Index
Sitagliptin Phosphate
Time Factors
Triazoles--therapeutic use
Venoms--therapeutic use